3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
10
Recurrence
4
Neurofibrosarcoma
2
Myeloproliferative Disorders
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Acute
2
Endometrial Neoplasms
2
Wilms Tumor
1
Vascular Neoplasms
1
Uterine Neoplasms
1
Uterine Diseases
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdoid Tumor
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Neoplasms by Site
1
Neoplasms
1
Myoepithelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell
1
Lymphoma
1
Liposarcoma, Myxoid
1
Interventions
Cyclophosphamide
3
Gemcitabine
2
regorafenib
1
liposomal doxorubicin
1
lenvatinib
1
fludarabine
1
alectinib
1
aldesleukin
1
Weight-Bearing
1
Taxes
1
Surveys and Questionnaires
1
Restraint, Physical
1
Range of Motion, Articular
1
Quality of Life
1
Proton Therapy
1
Platinum
1
Paclitaxel
1
Nivolumab
1
Metastasectomy
1
Masks
1
Lomustine
1
Irinotecan
1
Ipilimumab
1
Everolimus
1
Etoposide
1
Doxorubicin
1
Data Collection
1
Cisplatin
1
Carboplatin
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
selinexor
×
90 days
×
Clear all
No trials found.